Variability in immune infiltrates and HLA expression in cholangiocarci
- This topic has 0 replies, 1 voice, and was last updated 10 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Variability in immune infiltrates and HLA expression in cholangiocarcinoma.
“This information provides a sound rationale to consider immunotherapy in the treatment of cholangiocarcinoma, specifically with antibodies to check point molecules which enhance patients’ immune response against his own tumors.”
http://gicasym.org/content/123430-143
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.